4//SEC Filing
Jordan Scott 4
Accession 0001615219-19-000035
CIK 0001615219other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 9:59 PM ET
Size
5.4 KB
Accession
0001615219-19-000035
Insider Transaction Report
Form 4
Jordan Scott
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2019-09-10+10,000→ 10,000 totalExercise: $8.00Exp: 2029-09-10→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The grant has a 4-year vesting schedule with 25% vesting on September 30, 2020 and 1/12th of the balance vesting on the last day of each calendar quarter thereafter.
Documents
Issuer
Salarius Pharmaceuticals, Inc.
CIK 0001615219
Entity typeother
Related Parties
1- filerCIK 0001769747
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 9:59 PM ET
- Size
- 5.4 KB